Helianthrone derivatives as anti-cancer agents
US6229048A · kind A · utility
4Cited by
7References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 31, 2000 |
| Grant date | May 8, 2001 |
| Priority date | — |
| Expiry date | Jan 31, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/54
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating cancer comprising administering a 1,3,4,6-tetrahydroxy-helianthrone derivative. The compounds can be used in the absence of light irradiation or for photodynamic therapy of solid tumors wherein the tumor site is subjected to light irradiation after administration of the active ingredient. A preferred compound is 10,13-dimethyl-1,3,4,6-tetrahydroxy-helianthrone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.